Lipe & Dalton
- SEC CIK
- 0001570396
- Latest filing
- Jul 14, 2026
BIIB holding history
Biogen Inc. in every 13F filed by Lipe & Dalton, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BIIB overviewAll 13F holders of BIIBFull Q2 2026 holdings
- Shares (Q1 2022)
- 0
- Sold out in Q1 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2022 | 0 | $0 | 0.0% | −10,005−100.0% | Sold out | Holders |
| Q4 2021 | 10,005 | $2.40M | 1.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 10,005 | $2.83M | 1.5% | −70−0.7% | Reduced | Holders |
| Q2 2021 | 10,075 | $3.49M | 1.8% | −2,850−22.1% | Reduced | Holders |
| Q1 2021 | 12,925 | $3.62M | 2.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.